Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.02.2024 | Case report

Atezolizumab

Cerebellar ataxia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kapagan T, et al. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review. [Review] Journal of Oncology Pharmacy Practice 30: 201-205, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.1177/10781552231180594 [summarised from an abstract] Kapagan T, et al. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review. [Review] Journal of Oncology Pharmacy Practice 30: 201-205, No. 1, Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​1177/​1078155223118059​4 [summarised from an abstract]
Metadaten
Titel
Atezolizumab
Cerebellar ataxia
Publikationsdatum
01.02.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53294-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Phenytoin

Case report

Multiple drugs

Case report

Norepinephrine